Medimix Int'l

@MedimixInt

Full-service provider of advanced marketing research solutions for the life sciences industry worldwide.

Miami, FL
Vrijeme pridruživanja: kolovoz 2010.

Tweetovi

Blokirali ste korisnika/cu @MedimixInt

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @MedimixInt

  1. 4. pro 2019.

    If you are looking for in Oncology & Hematology, we have more than 350,000 patients records readily available in AML, CLL, CML, ALL, MM ... and more. We can also collect live upon your need in more than 50 countries in 24+ indications. Meet us at

    Poništi
  2. 14. stu 2019.

    In need of historical data? Within 48 hours, we can provide you with patient charts, each including 100+ data points. Here is an example of an insight for Gastric Cancer in Japan RWD Oct 2018-Oct 2019. Historical Data available in 22+ indications and 50+ countries.

    Poništi
  3. 26. ruj 2019.

    ESMO starts tomorrow! Medimix International is primed to show August RWD in 22 oncology/hematology indications, reported from EMRs by our global HCP panel in our LiveTracker series. Ask about our OfftheShelf historical data. Hope to see you there at Evidera booth #241!

    Poništi
  4. 24. ruj 2019.

    Almost time for ESMO! Medimix has August data to share from our LiveTrackers for oncology and hematology, reported from EMRs by our global HCP panel. Ask us also about OfftheShelf historical data. Come by the Evidera booth #241 or call to arrange a meeting.

    Poništi
  5. 23. ruj 2019.

    Finalizing year end budgets and updating strategies? This is a good time to cross-check your data against our historical RWD available in 48 hours! Scan the QR code and let us know what your data needs are. Get 5% discount with the promo code LNKD2019 -hematology

    Poništi
  6. 20. ruj 2019.

    Join us at ESMO in Barcelona at the PPD Booth #241 in Hall 3. Discover our LiveTracker and OfftheShelf offerings in oncology and hematology.

    Poništi
  7. 17. ruj 2019.

    Last chance to register for the webinar on Recent Biomarker Impact in Cancer Management. To register send an email to webinar@medimix.net

    Poništi
  8. 12. ruj 2019.

    Medimix is going to ESMO with August RWD on CLL from our LiveTracker CLL. Ex. below: illustrates drugs that predominate in 1st Line treatment. RWE from more than 2,300 HCPS, EU5 and Brazil (Sept 2018-April 2019). More RWD available in oncology-hematology in 22+ indications.

    Poništi
  9. 4. ruj 2019.

    Medimix is going to ESMO Congress Barcelona with the latest RWE from our syndicated LiveTracker Prostate Cancer. We've tracked prostate cancer patient journeys since 2016. Below - some recent findings on site metastasis by line of therapy (June 2018-2019).

    Poništi
  10. 14. kol 2019.

    What inspires us at Medimix? Knowing that behind our work are patients fighting diseases and professionals dedicated to improving their health & quality of life. They are the source of our passion & our commitment to helping them reach their goals.

    Poništi
  11. 7. kol 2019.

    MM, is increasing worldwide with a highly variable incidence rate among different countries. Medimix LiveTracker MM has followed more than 2,100 patients in Germany (Aug '18-Jun'19). See patient shares by condition broken down below.

    Poništi
  12. 31. srp 2019.

    Medimix Int'l Aug 1 World Lung Cancer Day. Lung cancer continues to be one of the most common cancers worldwide, claiming more lives yearly than breast, colon and prostate cancers combined! Medimix LiveTracker Lung has RWE reported from EMRs on 32,000 patients.

    Poništi
  13. 25. srp 2019.

    At the beach, mountains, year round--Sun protection (sun screen, protective clothing and limited time outdoors) is a must! Increasing ambient temperatures compound skin cancer risks. 5 yr. survival rate has increased, but melanoma is the most deadly skin cancer.

    Poništi
  14. 17. srp 2019.

    Bladder cancer in LatAm - what's happening? Medimix LiveTracker Bladder delivers reliable RWD, with more than 3K patient records collected from May 2018 to May 2019. Some of results shown below. Ask us what other cancers we are tracking.

    Poništi
  15. 10. srp 2019.

    DID YOU KNOW ... In a Medimix LiveTracker survey 1,826 oncologists responded that smoking is the most common risk factor both NSCLC and bladder. Smoking triples your chances of developing bladder cancer!

    Poništi
  16. 3. srp 2019.

    The team at Medimix wishes you a Happy 4th of July. Or do you think of it as Independence Day? Either way, celebrate safely with family, friends and those you hold dear.

    Poništi
  17. 26. lip 2019.

    Join Medimix in a salute to all cancer survivors and families! Today there is increased hope as cancer death rates continue to decline, improved screenings find tumors earlier, and new targeted treatments are developed to use the body's own defenses.

    Poništi
  18. 19. lip 2019.

    Personalized Medicine for AML: Medimix LiveTracker AML is tracking changes in treatment options with drugs targeting mutations like FLT3 and IDH2. RWD available for US and EU5, with options for up to 50+ countries.

    Poništi
  19. 13. lip 2019.

    Our Medimix team is looking for you at EHA! Let us show you a LiveTracker dashboard, with the latest real-time May RWD in a variety of hematology indications.

    Poništi
  20. 30. svi 2019.

    Medimix & Evidera are partnering to deliver real-time, RWE and insights to pharma, med device and diagnostic companies, leveraging data from Medimix's proprietary cloud-based visualization and analytics interface (LiveTracker). Join us at the PPD booth at ASCO

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·